Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Neurology

• Publication date

  2008-02-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1212/01.wnl.0000277527.69388.fePMID 17881720
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Polymyositis: an overdiagnosed entity.

  2004cited by this paper
• Polymyositis: an overdiagnosed entity.

  2004cited by this paper
• Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis

  2004cited by this paper
• Polymyositis: an overdiagnosed entity.

  2004cited by this paper
• Polymyositis: An overdiagnosed entity

  2004cited by this paper
• Clinical Trials Recruiting Section

  2004cited by this paper
• Polymyositis

  2003cited by this paper
• Polymyositis and dermatomyositis

  2002cited by this paper
• Inclusion body myositis.

  2002cited by this paper
• Inclusion body myositis: morphological clues to correct diagnosis.

  2002cited by this paper
• Targeted Somatic Mutagenesis in Mouse Epidermis

  2001cited by this paper
• Association of inclusion body myositis with subacute cutaneous lupus erythematosus

  2001cited by this paper
• Association myosite à inclusions et sarcoïdose : à propos de trois cas

  2001cited by this paper
• Patterns of muscle involvement in inclusion body myositis: Clinical and magnetic resonance imaging study

  2001cited by this paper
• Anti-Jo-1 positive inclusion body myositis with a marked and sustained clinical improvement after oral prednisone

  2001cited by this paper
• A prospective natural history study of inclusion body myositis

  2001cited by this paper
• [Inclusion body myositis associated with sacroidosis: a report of 3 cases].

  2001cited by this paper
• Rimmed vacuoles and the added value of SMI-31 staining in diagnosing sporadic inclusion body myositis.

  2001cited by this paper
• Disease progression in sporadic inclusion body myositis: Observations in 78 patients

  2000cited by this paper
• Inclusion Body Myositis—A Review

  1998cited by this paper
• Absence of characteristic features in two patients with inclusion body myositis

  1998cited by this paper
• Immune‐mediated conditions and antibodies associated with sporadic inclusion body myositis

  1998cited by this paper
• [Inclusion body myositis].

  1998cited by this paper
• Inclusion body myositis and paraproteinemia: Incidence and immunopathologic correlations

  1997cited by this paper
• Magnetic resonance imaging of the forearm as a diagnostic aid in patients with sporadic inclusion body myositis

  1997cited by this paper
• Inclusion Body Myositis, a Review

  1996cited by this paper
• Cytochrome c oxidase deficiencies in the muscle of patients with inflammatory myopathies

  1996cited by this paper
• Inclusion body myositis: Clinical and pathological boundaries

  1996cited by this paper
• Use of anti‐neurofilament antibody to identify paired‐helical filaments in inclusion‐body myositis

  1996cited by this paper
• Muscle biopsy

  1995cited by this paper
• Inclusion body myositis in association with rheumatoid arthritis.

  1994cited by this paper
• Mitochondrial DNA deletions in inclusion body myositis.

  1993cited by this paper
• Inclusion body myositis in association with vitamin B12 deficiency and Sjögren's syndrome.

  1992cited by this paper
• Amyloid filaments in inclusion body myositis. Novel findings provide insight into nature of filaments.

  1991cited by this paper
• Inclusion body myositis. Observations in 40 patients.

  1989cited by this paper
• Inclusion body myositis presenting as treatment-resistant polymyositis.

  1987cited by this paper
• Monoclonal antibody analysis of mononuclear cells in myopathies. III: Immunoelectron microscopy aspects of cell‐mediated muscle fiber injury

  1986cited by this paper
• Inclusion body myositis: a case with associated collagen vascular disease responding to treatment.

  1985cited by this paper
• Inclusion body myositis and Sjogren's syndrome.

  1985cited by this paper
• Inclusion body myositis and chronic immune thrombocytopenia.

  1984cited by this paper
• Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells

  1984cited by this paper
• Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis

  1984cited by this paper
• Ultrastructural changes in polymyositis.

  1979cited by this paper
• Inclusion body myositis

  1978cited by this paper
• Polymyositis and dermatomyositis (first of two parts).

  1975cited by this paper
• Inclusion body myositis.

  1971cited by this paper
• Muscular dystrophies, polymyositis, and other myopathies.

  1958cited by this paper
• The Perspective of Neurology in Regard to Polymyositis

  1954cited by this paper

• Evaluation of Muscle Disorders After Patients Have Been Placed In A Phenotypic Pattern

  2025cites this paper
• Inclusion Body Myositis.

  2025cites this paper
• Sporadic inclusion body myositis: Single center case series of 8 patients from a fifteen-year period

  2025cites this paper
• Classification of idiopathic inflammatory myopathies

  2025cites this paper
• Updates on Diagnostic Criteria of Inclusion Body Myositis.

  2025cites this paper
• Impact of muscle biopsy on the clinical decision-making process in patients with suspected idiopathic inflammatory myopathy.

  2024cites this paper
• NLRP3 inflammasome activation and altered mitophagy are key pathways in inclusion body myositis

  2024cites this paper
• Inclusion body myositis: Correcting mitochondfrial and lysosomal autophagy impairment as a potential therapeutic strategy.

  2024cites this paper
• Clinical, histopathological features and malignancy frequency of patients with idiopathic inflammatory myopathy

  2024cites this paper
• Quantitative whole-body muscle MRI in idiopathic inflammatory myopathies including polymyositis with mitochondrial pathology: indications for a disease spectrum

  2024cites this paper
• Cervical lower motor neuron syndromes: A diagnostic challenge.

  2024cites this paper
• Current biomarkers in inclusion body myositis

  2024cites this paper
• Autoimmune inflammatory myopathies.

  2023cites this paper
• Muscle fiber necroptosis in pathophysiology of idiopathic inflammatory myopathies and its potential as target of novel treatment strategy

  2023cites this paper
• Immunohistochemical Phenotype of T Cells Invading Muscle in Inclusion Body Myositis.

  2022cites this paper
• Inclusion body myositis: Update on the diagnostic and therapeutic landscape

  2022cites this paper
• Morphologic and Molecular Patterns of Polymyositis With Mitochondrial Pathology and Inclusion Body Myositis

  2022cites this paper
• Autoantibodies against four-and-a-half-LIM domain 1 (FHL1) in inflammatory myopathies: results from an Australian single-centre cohort

  2022cites this paper
• Clinical features and diagnostic tools in idiopathic inflammatory myopathies

  2021cites this paper
• Loss of TDP-43 function and rimmed vacuoles persist after T cell depletion in a xenograft model of sporadic inclusion body myositis

  2021cites this paper
• Skeletal muscle immunohistochemistry of acquired and hereditary myopathies

  2021cites this paper
• Revisiting the Role of GSK3, A Modulator of Innate Immunity, in Idiopathic Inclusion Body Myositis

  2021cites this paper
• Biomarker und Histologie bei idiopathischen inflammatorischen Myopathien

  2021cites this paper
• Overview on Diagnosis and Management of Polymyositis

  2021cites this paper
• Idiopathic Inflammatory Myositis

  2021cites this paper
• Diagnostic Accuracy of Anti-CN1A on the Diagnosis of Inclusion Body Myositis. A Hierarchical Bivariate and Bayesian Meta-analysis

  2021cites this paper
• Epidemiological characterization of patients with inflammatory myopathy in a fourth level hospital in Cali, Colombia

  2021cites this paper
• Diagnosis and Clinical Development of Sporadic Inclusion Body Myositis and Polymyositis With Mitochondrial Pathology: A Single-Center Retrospective Analysis.

  2021cites this paper
• Caracterización epidemiológica de pacientes con miopatía inflamatoria en un hospital de cuarto nivel en Cali, Colombia

  2021cites this paper
• Statin-Associated Muscle Symptoms

  2020cites this paper
• Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre.

  2020cites this paper
• A Randomized Phase 2 Trial of Antibiotic Prophylaxis Versus No Intervention for Muscle Biopsy in A Neurology Department.

  2020cites this paper
• Idiopathic Inflammatory Myopathy: From Muscle Biopsy to Serology

  2020cites this paper
• Apoptosis in idiopathic inflammatory myopathies with partial invasion; a role for CD8+ cytotoxic T cells?

  2020cites this paper
• Inclusion body myositis. Genetics, biomarkers and muscle biopsy

  2020cites this paper
• Accumulation of autophagosome cargo protein p62 is common in idiopathic inflammatory myopathies.

  2020cites this paper
• Where are we moving in the classification of idiopathic inflammatory myopathies?

  2020cites this paper
• Síndrome de Sjögren primario que debuta con polimiositis mitocondrial, neuropatía axonal y parálisis hipopotasémica: reporte de caso

  2020cites this paper
• Anti‐cN1A antibodies do not correlate with specific clinical, electromyographic, or pathological findings in sporadic inclusion body myositis

  2020cites this paper
• Statin-Associated Autoimmune Myopathy and Other Forms of Myositis

  2020cites this paper
• Sporadic Inclusion Body Myositis in the Rheumatology Clinic

  2020cites this paper
• The Low Prevalence of Inclusion Body Myositis in an Outpatient Rheumatology Myositis Cohort

  2020cites this paper
• Morphologische Charakteristika der Muskelbiopsie bei inflammatorischen Myopathien

  2019influential citation
• Diagnostic Imaging of Inflammatory Myopathies: New Concepts and a Radiological Approach

  2019cites this paper
• Inflammatory Muscle Diseases

  2019cites this paper
• Inclusion body myositis

  2019cites this paper
• Take two: Utility of the repeat skeletal muscle biopsy

  2019cites this paper
• [Idiopathic inflammatory myopathies. A review].

  2019cites this paper
• Inclusion body myositis: clinical features and pathogenesis

  2019cites this paper
• Sporadic inclusion body myositis: Diagnostic value of p62 immunostaining.

  2019cites this paper
• Diagnostic Challenge and Neuromuscular Junction Contribution to ALS Pathogenesis

  2019cites this paper
• İnflamatuar miyozitler: İdiyopatik mi? Çakışma mı? Paraneoplastik mi?

  2019cites this paper
• Immune-Mediated Myopathies.

  2019cites this paper
• Amyloid-PET: a new tool for diagnosing IBM?

  2019cites this paper
• Polymyositis and dermatomyositis – challenges in diagnosis and management

  2019cites this paper
• Myositis Mimics: The Differential Diagnosis of Myositis

  2019cites this paper
• Biologic therapy in the idiopathic inflammatory myopathies

  2019cites this paper
• A 75-Year-Old Man with Slowly Progressive Leg and Hand Weakness

  2019cites this paper
• A 54-Year-Old Man with Progressive Lower Limb Weakness and CK Elevation

  2019cites this paper
• A new in vitro model of polymyositis reveals CD8+ T cell invasion into muscle cells and its cytotoxic role

  2019cites this paper
• Classification and management of adult inflammatory myopathies.

  2018cites this paper
• Inclusion Body Myositis: Update on Pathogenesis and Treatment

  2018cites this paper
• Inflammatory Myopathies

  2018cites this paper
• Miopatías inflamatorias

  2018cites this paper
• Value of magnetic resonance imaging for evaluating muscle inflammation: insights from a new mouse model of myositis

  2018cites this paper
• Current Classification and Management of Inflammatory Myopathies

  2018cites this paper
• Tacrolimus-Induced Remission in Drug Resistant Inflammatory Myopathy: A Case Series

  2018cites this paper
• Physiopathologie des différentes myopathies inflammatoires

  2018cites this paper
• Electromyographic findings in sporadic inclusion body myositis.

  2018cites this paper
• A pattern-based approach to the interpretation of skeletal muscle biopsies

  2018cites this paper
• INFLAMMATORY MYOPATHIES

  2018cites this paper
• Polimiosite no diagnóstico diferencial de dor torácica aguda

  2017cites this paper
• Integrated classification of inflammatory myopathies

  2017cites this paper
• Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional Outcomes.

  2017cites this paper
• [Polymyositis secondary to a non-Hodgkin's lymphoma].

  2017cites this paper
• Overlapping features of polymyositis and inclusion body myositis in HIV-infected patients

  2017cites this paper
• Inclusion body myositis: advancements in diagnosis, pathomechanisms, and treatment

  2017cites this paper
• Cytokines as Orchestrators of Skeletal Muscle Tissue Maintenance and the Inflammation Associated With Acquired Autoimmune and Hereditary Muscle Diseases

  2017cites this paper
• Nodular Amyloidosis Overlapping and Polymyositis in a Patient with Skin Manifestations Lupus Fax: Case Report

  2017cites this paper
• AIIMDs: An Integrated Framework of Automatic Idiopathic Inflammatory Myopathy Diagnosis for Muscle

  2017cites this paper
• Advances in inclusion body myositis: genetics, pathogenesis and clinical aspects

  2017cites this paper
• Clinicopathologic features of myositis patients with CD8-MHC-1 complex pathology

  2017cites this paper
• Which nonautoimmune myopathies are most frequently misdiagnosed as myositis?

  2017cites this paper
• Miopatias autoimunes sistêmicas

  2017cites this paper
• Immune and myodegenerative pathomechanisms in inclusion body myositis

  2017cites this paper
• ANTI- C N1A ANTIBODIES IN SOUTH AUSTRALIAN PATIENTS WITH INCLUSION BODY MYOSITIS

  2016cites this paper
• Inclusion Body Myositis

  2016cites this paper
• The Clinical and Pathological Spectrum of Idiopathic Inflammatory Myopathies : Implications for pathogenesis, classification and diagnosis

  2016influential citation
• Leitlinie Dermatomyositis – Auszug aus der interdisziplinären S2k‐Leitlinie zu Myositissyndromen der deutschen Gesellschaft für Neurologie

  2016cites this paper
• The Spectrum of Inflammatory Myopathies: Dermatomyositis, Polymyositis, Necrotizing Myositis, and Inclusion-Body Myositis

  2016cites this paper
• Diagnostic criteria for inclusion body myositis

  2016cites this paper
• Autoimmune muscle disease.

  2016cites this paper
• Idiopathic Inflammatory Myopathies: Clinical Approach and Management

  2016cites this paper
• Seminarios de la Fundación Española de Reumatología

  2016cites this paper
• Guidelines on dermatomyositis – excerpt from the interdisciplinary S2k guidelines on myositis syndromes by the German Society of Neurology

  2016cites this paper
• Development and evaluation of a standardized ELISA for the determination of autoantibodies against cN-1A (Mup44, NT5C1A) in sporadic inclusion body myositis

  2016cites this paper
• Association of inclusion body myositis with T cell large granular lymphocytic leukaemia.

  2016cites this paper
• Anti‐ C N1A antibodies in South Australian patients with inclusion body myositis

  2016cites this paper
• Sporadic inclusion body myositis: A review of recent clinical advances and current approaches to diagnosis and treatment.

  2016cites this paper
• Low back pain with radicular symptoms as a presentation of hereditary neuropathy with liability to pressure palsies: the diagnostic challenge of an atypical presentation

  2016cites this paper